Diamorphine Withdrawn Phase 2 Trials for Opioid-Related Disorders / Heroin Dependence Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00000326Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1
NCT00000327Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2